IM Cannabis Q1 EPS $(0.31) Misses $(0.20) Estimate, Sales $8.95M Miss $10.60M Estimate
IM Cannabis Q1 EPS $(0.31) Misses $(0.20) Estimate, Sales $8.95M Miss $10.60M Estimate
IM Cannabis第一季度每股收益（0.31）未達到預期（0.20）美元，銷售額爲895萬美元，未達到1,060萬美元的預期
IM Cannabis (NASDAQ:IMCC) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.20) by 55 percent. This is a 1650 percent decrease over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $8.95 million which missed the analyst consensus estimate of $10.60 million by 15.58 percent. This is a 8.16 percent decrease over sales of $9.74 million the same period last year.
IM Cannabis（納斯達克股票代碼：IMCC）公佈的季度虧損爲每股0.31美元，比分析師普遍預期的0.20美元（0.20美元）低55％。與去年同期的每股收益0.02美元相比，下降了1650％。該公司公佈的季度銷售額爲895萬美元，比分析師普遍預期的1,060萬美元低15.58％。這比去年同期的974萬美元銷售額下降了8.16％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。